Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Ana I. Torres-Suárez"'
Autor:
Cristina Martín-Sabroso, Mario Alonso-González, Ana Fernández-Carballido, Juan Aparicio-Blanco, Damián Córdoba-Díaz, Federico Navarro-García, Manuel Córdoba-Díaz, Ana I. Torres-Suárez
Publikováno v:
Pharmaceuticals, Vol 15, Iss 1, p 2 (2021)
Accumulation of cystine crystals in the cornea of patients suffering from cystinosis is considered pathognomonic and can lead to severe ocular complications. Cysteamine eye drop compounded formulations, commonly prepared by hospital pharmacy services
Externí odkaz:
https://doaj.org/article/4241f55208fc4496a86a4b1665463ea2
Autor:
Ana I. Fraguas-Sánchez, Ana I. Torres-Suárez, Marie Cohen, Florence Delie, Daniel Bastida-Ruiz, Lucile Yart, Cristina Martin-Sabroso, Ana Fernández-Carballido
Publikováno v:
Pharmaceutics, Vol 12, Iss 5, p 439 (2020)
The intraperitoneal administration of chemotherapeutics has emerged as a potential route in ovarian cancer treatment. Nanoparticles as carriers for these agents could be interesting by increasing the retention of chemotherapeutics within the peritone
Externí odkaz:
https://doaj.org/article/5a5f09f0102742a9b9c3737e3a57e417
Autor:
Ambra Altimari, Carla Asquer, Elena Babini, Mario Baldini, Giovanni Benelli, Ángel A. Carbonell-Barrachina, Aarón Ángel Carbonell-Pedro, Gianluca Carboni, Belén Cárceles, Flavia Casciano, Giuseppina Crescente, Francesco Danuso, Gaia Dorigo, Víctor Hugo Durán-Zuazo, Marialuisa Formato, Ana I Fraguas-Sánchez, Iván Francisco García-Tejero, Andrea Gianotti, Jorma Heikkinen, Luca Iseppi, Hanán Issa-Issa, Noora Jokinen, Reijo Lappalainen, Leontina Lipan, Filippo Maggi, Roberto Mancinelli, Eugenia Mazzara, E. Melis, Federico Nassivera, Lorenzo Nissen, Luis Noguera-Artiaga, Severina Pacifico, Patrizia Papetti, Maria T. Pecoraro, Pedro Pérez-Bermúdez, Riccardo Petrelli, Simona Piccolella, Emanuele Radicetti, Renato Ricciardi, Belén Cárceles Rodríguez, Alejandro Rognoni Martínez, Baltasar Gálvez Ruiz, Ayobami Salami, Efisio Antonio Scano, Esther Sendra, Antoni Szumny, Laura Tomppo, Jacopo Torresi, Ana I. Torres-Suárez, Anna K. Żołnierczyk
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ae94d472255568601e60eb14a77431b
https://doi.org/10.1016/b978-0-323-89867-6.00017-2
https://doi.org/10.1016/b978-0-323-89867-6.00017-2
Publikováno v:
Handbook of Cancer and Immunology ISBN: 9783030809621
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::449caf409df7e6bfabf5c5485703d762
https://doi.org/10.1007/978-3-030-80962-1_294-1
https://doi.org/10.1007/978-3-030-80962-1_294-1
Publikováno v:
Handbook of Cancer and Immunology ISBN: 9783030809621
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2b78d6c3dc36e99921b7cca410adcefa
https://doi.org/10.1007/978-3-030-80962-1_118-1
https://doi.org/10.1007/978-3-030-80962-1_118-1
Autor:
Ana Fernández-Carballido, Dolores Barreda-Hernández, Julia Sánchez-Gundín, Cristina Martín-Sabroso, Ana I. Torres-Suárez
Publikováno v:
International e-Conference on Cancer Research 2019.
Autor:
Ana I. Torres-Suárez, Miguel Rodríguez-Amaro, Juan Aparicio-Blanco, Victor Sebastian, Héctor C. García-Díaz
Publikováno v:
Journal of biomedical nanotechnology. 15(6)
The empirical development of nanocarriers has unfortunately led to high attrition rates in clinical trials. This underpins the importance of the rational design of nanomedicines to achieve efficient disease-driven therapies. Since particle size certa
Autor:
Karla Slowing, Ana I. Torres-Suárez, Ignacio A. Romero, Juan Aparicio-Blanco, Luis García-García, David Male
Diseases affecting the central nervous system (CNS) should be regarded as a major health challenge due to the current lack of effective treatments given the hindrance to brain drug delivery imposed by the blood-brain barrier (BBB). Since efficient br
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2f87ae6f5c1be68923578214b9616e2
http://oro.open.ac.uk/60126/1/60126.pdf
http://oro.open.ac.uk/60126/1/60126.pdf
Publikováno v:
European Journal of Pharmaceutics and Biopharmaceutics
European Journal of Pharmaceutics and Biopharmaceutics, Elsevier, 2019, 134, pp.126-137. ⟨10.1016/j.ejpb.2018.11.020⟩
European Journal of Pharmaceutics and Biopharmaceutics, Elsevier, 2019, 134, pp.126-137. ⟨10.1016/j.ejpb.2018.11.020⟩
International audience; The therapeutic potential of cannabinoids has been truly constrained heretofore due to their strong psychoactive effects and their high lipophilicity. In this context, precisely due to the lack of psychoactive properties, cann
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed21a59c217cc3d27a4511ab36466f9b
https://hal.univ-angers.fr/hal-02490875
https://hal.univ-angers.fr/hal-02490875